DE60228988D1 - Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen - Google Patents
Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzenInfo
- Publication number
- DE60228988D1 DE60228988D1 DE60228988T DE60228988T DE60228988D1 DE 60228988 D1 DE60228988 D1 DE 60228988D1 DE 60228988 T DE60228988 T DE 60228988T DE 60228988 T DE60228988 T DE 60228988T DE 60228988 D1 DE60228988 D1 DE 60228988D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- disorders
- monohyroxycarbamezepine
- attractive
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0127178A GB0127178D0 (en) | 2001-11-12 | 2001-11-12 | Organic compounds |
GB0127177A GB0127177D0 (en) | 2001-11-12 | 2001-11-12 | Organic compounds |
GB0127176A GB0127176D0 (en) | 2001-11-12 | 2001-11-12 | Organic compounds |
PCT/EP2002/012578 WO2003042182A1 (en) | 2001-11-12 | 2002-11-11 | Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60228988D1 true DE60228988D1 (de) | 2008-10-30 |
Family
ID=27256320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60228988T Expired - Lifetime DE60228988D1 (de) | 2001-11-12 | 2002-11-11 | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen |
Country Status (21)
Country | Link |
---|---|
US (1) | US20050004102A1 (de) |
EP (2) | EP2048135A1 (de) |
JP (1) | JP2005511623A (de) |
KR (1) | KR20050044396A (de) |
CN (1) | CN100506797C (de) |
AT (1) | ATE408602T1 (de) |
AU (2) | AU2007201925B2 (de) |
BR (1) | BR0214060A (de) |
CA (1) | CA2463970A1 (de) |
DE (1) | DE60228988D1 (de) |
ES (1) | ES2314111T3 (de) |
HK (1) | HK1068350A1 (de) |
HU (1) | HUP0402381A3 (de) |
IL (1) | IL161700A0 (de) |
MX (1) | MXPA04004470A (de) |
NO (1) | NO20041955L (de) |
NZ (1) | NZ556026A (de) |
PL (1) | PL368591A1 (de) |
PT (1) | PT1446383E (de) |
TW (1) | TW200300090A (de) |
WO (1) | WO2003042182A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0303615D0 (en) * | 2003-02-17 | 2003-03-19 | Novartis Ag | Use of organic compounds |
MXPA05008729A (es) * | 2003-02-17 | 2005-09-20 | Novartis Ag | Uso de s-10-hidroxi-10, 11-dihidro-carbamazepina para el tratamiento de ansiedad y trastornos bipolares. |
TW200502222A (en) * | 2003-04-02 | 2005-01-16 | Novartis Ag | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
GB0307860D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Organic compounds |
US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
KR101236227B1 (ko) * | 2005-05-06 | 2013-02-21 | 바이알 - 포르텔라 앤드 씨에이 에스에이 | 에스리카르바제핀 아세테이트 및 그의 사용방법 |
GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH505101A (de) | 1969-03-31 | 1971-03-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Azepinderivaten |
EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
PT101732B (pt) * | 1995-06-30 | 1997-12-31 | Portela & Ca Sa | Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso |
-
2002
- 2002-11-11 DE DE60228988T patent/DE60228988D1/de not_active Expired - Lifetime
- 2002-11-11 NZ NZ556026A patent/NZ556026A/en not_active IP Right Cessation
- 2002-11-11 TW TW091133018A patent/TW200300090A/zh unknown
- 2002-11-11 BR BR0214060-8A patent/BR0214060A/pt not_active IP Right Cessation
- 2002-11-11 MX MXPA04004470A patent/MXPA04004470A/es active IP Right Grant
- 2002-11-11 KR KR1020047007110A patent/KR20050044396A/ko not_active Application Discontinuation
- 2002-11-11 HU HU0402381A patent/HUP0402381A3/hu unknown
- 2002-11-11 CN CNB028224442A patent/CN100506797C/zh not_active Expired - Fee Related
- 2002-11-11 EP EP08163175A patent/EP2048135A1/de not_active Withdrawn
- 2002-11-11 IL IL16170002A patent/IL161700A0/xx unknown
- 2002-11-11 AT AT02783080T patent/ATE408602T1/de not_active IP Right Cessation
- 2002-11-11 JP JP2003544018A patent/JP2005511623A/ja active Pending
- 2002-11-11 US US10/494,816 patent/US20050004102A1/en not_active Abandoned
- 2002-11-11 EP EP02783080A patent/EP1446383B1/de not_active Expired - Lifetime
- 2002-11-11 PT PT02783080T patent/PT1446383E/pt unknown
- 2002-11-11 WO PCT/EP2002/012578 patent/WO2003042182A1/en active IP Right Grant
- 2002-11-11 PL PL02368591A patent/PL368591A1/xx not_active Application Discontinuation
- 2002-11-11 CA CA002463970A patent/CA2463970A1/en not_active Abandoned
- 2002-11-11 ES ES02783080T patent/ES2314111T3/es not_active Expired - Lifetime
-
2004
- 2004-05-12 NO NO20041955A patent/NO20041955L/no not_active Application Discontinuation
-
2005
- 2005-01-24 HK HK05100629.4A patent/HK1068350A1/xx not_active IP Right Cessation
-
2007
- 2007-05-01 AU AU2007201925A patent/AU2007201925B2/en not_active Ceased
-
2009
- 2009-04-08 AU AU2009201388A patent/AU2009201388A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR0214060A (pt) | 2004-10-13 |
JP2005511623A (ja) | 2005-04-28 |
HUP0402381A2 (hu) | 2005-03-29 |
WO2003042182A1 (en) | 2003-05-22 |
PL368591A1 (en) | 2005-04-04 |
PT1446383E (pt) | 2008-12-29 |
TW200300090A (en) | 2003-05-16 |
CA2463970A1 (en) | 2003-05-22 |
IL161700A0 (en) | 2004-09-27 |
NZ556026A (en) | 2008-06-30 |
KR20050044396A (ko) | 2005-05-12 |
EP1446383B1 (de) | 2008-09-17 |
MXPA04004470A (es) | 2005-05-16 |
ES2314111T3 (es) | 2009-03-16 |
EP2048135A1 (de) | 2009-04-15 |
ATE408602T1 (de) | 2008-10-15 |
AU2007201925B2 (en) | 2009-06-04 |
AU2007201925A1 (en) | 2007-05-24 |
US20050004102A1 (en) | 2005-01-06 |
HUP0402381A3 (en) | 2008-01-28 |
NO20041955L (no) | 2004-05-12 |
CN100506797C (zh) | 2009-07-01 |
EP1446383A1 (de) | 2004-08-18 |
CN1585753A (zh) | 2005-02-23 |
AU2009201388A1 (en) | 2009-05-07 |
HK1068350A1 (en) | 2005-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60231804D1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomöostase störungen | |
DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
ATE417606T1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
ATE455092T1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
DE60320007D1 (de) | Phenethanolamin-derivate zur behandlung von atemwegserkrankungen | |
DE602006008641D1 (de) | Herstellung und anwendung von tetrahydropyrrolo ä3, 2-cüpyridin-4-onderivaten zur behandlung von obesitas und psychiatrischen und neurologischen erkrankungen | |
BG106095A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
HK1068350A1 (en) | Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain | |
BR0306855A (pt) | Método para o tratamento de distúrbios cognitivos | |
ATE464048T1 (de) | Behandlung von alzheimer-krankheit und verwandten zuständen | |
DE60111574D1 (de) | Bisphosphonate-enthaltenden zusammensetzungen zur vorbeugung und/oder heilung von metabolischen knochenkrankheiten, verfahren zu ihren herstellung und benutzung dieser zusammensetzungen | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
DE60128009D1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
MXPA04010816A (es) | Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares. | |
DE502004012196D1 (de) | Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen | |
ATE384520T1 (de) | Kombinierte verwendung von einem fibrat und von orlistat zur behandlung von obesitas | |
BR0206918A (pt) | Uso de iloperidona | |
DE60219495D1 (de) | Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten | |
DE60215219D1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
ATE288263T1 (de) | Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis) | |
ATE286390T1 (de) | Felabamat-derivate zur behandlung von neuropathischem schmerz | |
ATE418558T1 (de) | Darstellung von 1-aza-2-oxadibenzoäe,hüazulenen und deren verwendung bei der herstellung pharmazeutischer formulierungen zur behandlung und prävention von krankheiten und erkrankungen des zentralen nervensystems | |
DE60027282D1 (de) | Verwendung von l-threo-methylphenidate zur Herstellung eines Medikaments für die Behandlung von Depression | |
CY1115241T1 (el) | Χρηση φθοριωμενων τριαζολων για τη θεραπευτικη αντιμετωπιση συναισθηματικων διαταραχων ή διαταραχων της προσοχης |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |